AdvanSix (ASIX) to Release Earnings on Friday

AdvanSix (NYSE:ASIXGet Free Report) is set to post its quarterly earnings results before the market opens on Friday, May 3rd. Analysts expect AdvanSix to post earnings of ($0.66) per share for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.

AdvanSix (NYSE:ASIXGet Free Report) last announced its earnings results on Friday, February 16th. The company reported ($0.17) earnings per share for the quarter, topping the consensus estimate of ($0.19) by $0.02. AdvanSix had a net margin of 3.56% and a return on equity of 6.98%. The firm had revenue of $382.21 million for the quarter, compared to the consensus estimate of $335.80 million. On average, analysts expect AdvanSix to post $1 EPS for the current fiscal year and $4 EPS for the next fiscal year.

AdvanSix Price Performance

Shares of ASIX opened at $25.26 on Wednesday. AdvanSix has a fifty-two week low of $23.92 and a fifty-two week high of $40.85. The firm’s 50 day moving average price is $27.14 and its 200 day moving average price is $27.16. The company has a quick ratio of 0.58, a current ratio of 1.17 and a debt-to-equity ratio of 0.23. The company has a market cap of $674.44 million, a P/E ratio of 13.29 and a beta of 1.73.

AdvanSix Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 18th. Shareholders of record on Monday, March 4th were given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.53%. The ex-dividend date of this dividend was Friday, March 1st. AdvanSix’s dividend payout ratio is presently 33.68%.

Insider Activity at AdvanSix

In related news, CEO Erin N. Kane sold 5,000 shares of the stock in a transaction on Thursday, March 28th. The shares were sold at an average price of $28.30, for a total value of $141,500.00. Following the transaction, the chief executive officer now directly owns 557,755 shares of the company’s stock, valued at approximately $15,784,466.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, CEO Erin N. Kane sold 5,000 shares of the business’s stock in a transaction dated Thursday, March 28th. The stock was sold at an average price of $28.30, for a total value of $141,500.00. Following the transaction, the chief executive officer now owns 557,755 shares in the company, valued at approximately $15,784,466.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Erin N. Kane sold 3,002 shares of the business’s stock in a transaction dated Thursday, April 4th. The shares were sold at an average price of $28.08, for a total value of $84,296.16. Following the completion of the transaction, the chief executive officer now owns 552,755 shares in the company, valued at approximately $15,521,360.40. The disclosure for this sale can be found here. Insiders have sold 17,387 shares of company stock valued at $486,481 in the last ninety days. Insiders own 5.20% of the company’s stock.

Analysts Set New Price Targets

Separately, Stifel Nicolaus reissued a “buy” rating and issued a $40.00 price objective on shares of AdvanSix in a research report on Tuesday, April 9th.

Get Our Latest Stock Analysis on ASIX

About AdvanSix

(Get Free Report)

AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.

See Also

Earnings History for AdvanSix (NYSE:ASIX)

Receive News & Ratings for AdvanSix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix and related companies with MarketBeat.com's FREE daily email newsletter.